Alpa Laboratories Ltd (ALPA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 476646,
    "name": "Alpa Laboratorie",
    "stock_name": "Alpa Laboratorie",
    "full_name": "Alpa Laboratories Ltd",
    "name_url": "stocks-analysis/alpa-laboratorie",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "66.03",
    "chg": -1.33,
    "chgp": "-1.97%",
    "dir": -1,
    "prev_price": "67.36",
    "mcapval": "145.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532878,
    "symbol": "ALPA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE385I01010",
    "curr_date": "Jul 31, 03:30 PM",
    "curr_time": "14:40 PM",
    "last_traded_at": "Jul 31, 03:30 PM IST",
    "bse_nse_vol": "12.1 k",
    "exc_status": "Active",
    "traded_date": "Jul 31, 2026",
    "traded_date_str": "2026 07 31",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alpa-laboratorie-476646-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Alpa Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-sell-4128581",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlpaLaboratorie_mojoScore_4128581.png",
        "date": "2026-07-30 10:10:03",
        "description": "Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 30 July 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-sell-4108036",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlpaLaboratorie_mojoScore_4108036.png",
        "date": "2026-07-19 10:10:03",
        "description": "Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 July 2026, providing investors with an up-to-date perspective on its performance and outlook."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-sell-4092284",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlpaLaboratorie_mojoScore_4092284.png",
        "date": "2026-07-07 10:10:03",
        "description": "Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-sell-4074070",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlpaLaboratorie_mojoScore_4074070.png",
        "date": "2026-06-26 10:10:03",
        "description": "Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-sell-4054246",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlpaLaboratorie_mojoScore_4054246.png",
        "date": "2026-06-15 10:10:04",
        "description": "Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Alpa Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alpa-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-4029215",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlpaLaboratorie_valuationdot_4029215.png",
        "date": "2026-06-02 08:02:11",
        "description": "Alpa Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a risky to an attractive valuation grade. This change, coupled with its current price-to-earnings (P/E) ratio of 9.85 and price-to-book value (P/BV) of 0.79, positions the stock as a potentially undervalued opportunity relative to its historical averages and peer group."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-sell-4026072",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlpaLaboratorie_mojoScore_4026072.png",
        "date": "2026-06-01 10:10:35",
        "description": "Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 June 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Alpa Laboratories Q4 FY26: Profit Recovery Masks Deeper Revenue Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/alpa-laboratories-q4-fy26-profit-recovery-masks-deeper-revenue-concerns-4024038",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlpaLaboratorie_quaterlyResult_4024038.png",
        "date": "2026-05-30 20:18:37",
        "description": "Alpa Laboratories Ltd., a micro-cap pharmaceutical manufacturer with a market capitalisation of ₹148.00 crores, reported a net profit of ₹1.38 crores for Q4 FY26, marking a sharp recovery from the previous year's loss of ₹2.12 crores. However, the positive earnings reversal conceals troubling revenue trends, as net sales declined 21.34% year-on-year to ₹31.40 crores, raising questions about the sustainability of the company's business momentum in an otherwise buoyant pharmaceutical sector."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-strong-sell-4000845",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlpaLaboratorie_mojoScore_4000845.png",
        "date": "2026-05-20 10:10:21",
        "description": "Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 20 May 2026, providing investors with the latest perspective on the company’s position."
      }
    ],
    "total": 121,
    "sid": "476646",
    "stock_news_url": "https://www.marketsmojo.com/news/alpa-laboratories-476646"
  },
  "announcements": [
    {
      "caption": "Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Materiality Of Information",
      "datetime": "29-Jul-2026",
      "details": "Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Cessation",
      "datetime": "22-Jul-2026",
      "details": "Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we hereby inform you that Ms. Jyoti Jain has ceased to be an Independent Director of the company upon completion of her tenurewith effect from the close of business hours on 21st july 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
      "datetime": "08-Jul-2026",
      "details": "Ms.Yashoda Patidar has resigned from the post of Company Secretary & Complaince Officer w.e.f. 26th July 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Alpa Laboratories Ltd is Rated Sell

2026-07-30 10:10:03

Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 30 July 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Alpa Laboratories Ltd is Rated Sell

2026-07-19 10:10:03

Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 July 2026, providing investors with an up-to-date perspective on its performance and outlook.

Read full news article

Alpa Laboratories Ltd is Rated Sell

2026-07-07 10:10:03

Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Alpa Laboratories Ltd is Rated Sell

2026-06-26 10:10:03

Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Alpa Laboratories Ltd is Rated Sell

2026-06-15 10:10:04

Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Alpa Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-06-02 08:02:11

Alpa Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a risky to an attractive valuation grade. This change, coupled with its current price-to-earnings (P/E) ratio of 9.85 and price-to-book value (P/BV) of 0.79, positions the stock as a potentially undervalued opportunity relative to its historical averages and peer group.

Read full news article

Alpa Laboratories Ltd is Rated Sell

2026-06-01 10:10:35

Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Alpa Laboratories Q4 FY26: Profit Recovery Masks Deeper Revenue Concerns

2026-05-30 20:18:37

Alpa Laboratories Ltd., a micro-cap pharmaceutical manufacturer with a market capitalisation of ₹148.00 crores, reported a net profit of ₹1.38 crores for Q4 FY26, marking a sharp recovery from the previous year's loss of ₹2.12 crores. However, the positive earnings reversal conceals troubling revenue trends, as net sales declined 21.34% year-on-year to ₹31.40 crores, raising questions about the sustainability of the company's business momentum in an otherwise buoyant pharmaceutical sector.

Read full news article

Alpa Laboratories Ltd is Rated Strong Sell

2026-05-20 10:10:21

Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 20 May 2026, providing investors with the latest perspective on the company’s position.

Read full news article

View All News